Meet the editors

Dr. S. Sundaresan has been working in the field of cancer chemoprevention, cancer immunotherapy, and tumor marker detection. Translational research (TR) has been described as translating research into medical practice and translating science into better healthcare. Translational research on tumor biomarkers has successfully promoted the development of tumor treatment and has brought new hope for cancer patients. It is

important to direct cancer research on diagnosis and treatment toward applying fundamental research findings to the clinic as soon as possible, and applying novel tumor molecular markers to early diagnosis, targeted therapy, and individualized treatment. Focused medical treatment should be given through the analysis of new tumor biomarkers and appropriate treatments. Dr. S. Sundaresan has been working with oral cancer and cancer biomarkers. There are newer molecular markers that are of clinical significance and they need to be studied in various populations. The administration of indoles and triterpenes for preventive and curative effects was studied in laboratory animals. Dr. S. Sundaresan's research study also demonstrates interferon beta synergistically works with chemotherapeutic drug cisplatin for liver, breast, and cervix cancer cells.

Dr. Yeun-Hwa Gu is working as a Professor for the Department of Radiation Oncology, Graduate School of Health Science, Junshin Gakuen University, Japan. He has worked as a Professor for the Department of Health and Medicine, Suzuka Medical Science University for 15 years. He graduated from the University of Tokyo with his Master's and Ph.D. degrees. He is currently working as an academic advisory committee member of the Korea Society

of Health Sciences and academic director of the Korean Ultrasound Cancer Therapy (HIFU) Society and co-researcher of the Russia Space Radiation Chemistry Protection Study Group. He is a board member and editor of the International Journal of Food Science, Editor-in-Chief of Clinical Microbiology and Infectious Diseases and Current Traditional Medicine. He has published more than 250 papers in various peer-reviewed journals.

Contents

in Cancer

*and Tao Lu*

IL10 as Cancer Biomarker

*Carmen Maldonado-Bernal*

for Diagnostics with Antibodies

Chalcones: Potential Anticancer Agents *by Adam McCluskey and Cecilia Russell*

*by Yeun-Hwa Gu*

with Hypoxia

Stem Cells

**Preface XI**

**Chapter 1 1**

**Chapter 2 25**

**Chapter 3 43**

**Chapter 4 65**

**Chapter 5 75**

**Chapter 6 101**

**Chapter 7 115**

**Chapter 8 127**

New Screening for the Development of Radioprotectors: Radioprotection

Evaluation by Monte Carlo Simulation of Doses Distribution in Tumors

Bozepinib: A Promising Selective Derivative Targeting Breast Cancer

Discovery of Small Molecule Inhibitors for Histone Methyltransferases

*by Aishat A. Motolani, Mengyao Sun, Matthew Martin, Steven Sun* 

Ion Channels and Transporters as Cancer Biomarkers and Targets

*by Maria Teresa Gonzalez-Garza, Delia Elva Cruz-Vega and* 

*by Jessica Iorio, Claudia Duranti and Elena Lastraioli*

Translational Perspective in Hepatocellular Carcinoma *by Sivapatham Sundaresan and Palanirasu Rajapriya*

and Anti-Cancer Effect of β-Glucan (*Enterococcus faecalis*)

*by Mirko Salomón Alva-Sánchez and Thatiane Alves Pianoschi*

*by Joaquín M. Campos, Ana Conejo-García and Olga Cruz-López*
